Fasciectomy vs Collagenase Injection in Recurrent Dupuytren Disease
Surgical Fasciectomy Versus Collagenase Injection in Treating Recurrent Dupuytren Disease: a Randomized Controlled Trial
Sponsor: Region Skane
This PHASE4 trial investigates Dupuytren Disease of Finger and is currently ongoing. Region Skane leads this study, which shows 12 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
May 2025 — Present [monthly]
Active Not Recruiting PHASE4
-
Sep 2024 — May 2025 [monthly]
Active Not Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
-
Dec 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE4
-
Nov 2022 — Dec 2023 [monthly]
Active Not Recruiting PHASE4
Status: Enrolling By Invitation → Active Not Recruiting
▶ Show 7 earlier versions
-
Dec 2021 — Nov 2022 [monthly]
Enrolling By Invitation PHASE4
-
Jan 2021 — Dec 2021 [monthly]
Enrolling By Invitation PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Enrolling By Invitation PHASE4
-
Oct 2019 — Dec 2020 [monthly]
Enrolling By Invitation PHASE4
-
Jun 2018 — Oct 2019 [monthly]
Enrolling By Invitation PHASE4
-
May 2018 — Jun 2018 [monthly]
Enrolling By Invitation PHASE4
-
Feb 2018 — May 2018 [monthly]
Enrolling By Invitation PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Region Skane
For direct contact, visit the study record on ClinicalTrials.gov .